Patents by Inventor Bong Jun Jung

Bong Jun Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITION FOR TREATING CLIMACTERIC DISORDER COMPRISING LACTOBACILLUS GASSERI BNR17
    Publication number: 20230124145
    Abstract: The present invention relates to a pharmaceutical composition for treating climacteric disorder, containing Lactobacillus gasseri BNR17 as an active ingredient, and a functional food composition for preventing or ameliorating climacteric symptoms, containing Lactobacillus gasseri BNR17 as an active ingredient. Lactobacillus gasseri BNR17 according to the present invention has an excellent effect of treating, preventing, or ameliorating various climacteric symptoms, such as amelioration of osteoporosis, which is the representative symptom of climacterium, amelioration of involutional depression, amelioration of pain hypersensitivity, and amelioration of vaginal dryness.
    Type: Application
    Filed: February 17, 2021
    Publication date: April 20, 2023
    Inventors: Han-Oh PARK, Myeong Hee KIM, Bong Jun JUNG, Wonbeak YOO
  • METHOD FOR PREPARING MICROBIAL PREPARATION AND MICROBIAL PREPARATION PRODUCED BY THE SAME
    Publication number: 20200255795
    Abstract: The present disclosure relates to a method for preparing an aglycone or hydrolyzed glycoside converted from a glycoside and, specifically, to a method for preparing an aglycone or hydrolyzed glycoside from a glycoside by converting a glycoside into an aglycone form or hydrolyzed glycoside by using a microorganism producing ?-glycosidase, and then recovering the aglycone or hydrolyzed glycoside accumulated in the cells of the microorganism.
    Type: Application
    Filed: April 26, 2020
    Publication date: August 13, 2020
    Inventors: Dae Kyun Chung, Hangeun Kim, Seung Su Lee, Bong Jun Jung, Hye Rim Kim, Yoon Doo Lee, Jae Yeon Park, Boram Jeon, Seong Jae Kim
  • Method for preparing microbial preparation and microbial preparation produced by the same
    Patent number: 10676708
    Abstract: The present disclosure relates to a method for preparing an aglycone or hydrolyzed glycoside converted from a glycoside and, specifically, to a method for preparing an aglycone or hydrolyzed glycoside from a glycoside by converting a glycoside into an aglycone form or hydrolyzed glycoside by using a microorganism producing ?-glycosidase, and then recovering the aglycone or hydrolyzed glycoside accumulated in the cells of the microorganism.
    Type: Grant
    Filed: September 30, 2015
    Date of Patent: June 9, 2020
    Assignee: RNA INC.
    Inventors: Dae Kyun Chung, Hangeun Kim, Seung Su Lee, Bong Jun Jung, Hye Rim Kim, Yoon Doo Lee, Jae Yeon Park, Boram Jeon, Seong Jae Kim
  • METHOD FOR PREPARING MICROBIAL PREPARATION AND MICROBIAL PREPARATION PRODUCED BY THE SAME
    Publication number: 20170306289
    Abstract: The present disclosure relates to a method for preparing an aglycone or hydrolyzed glycoside converted from a glycoside and, specifically, to a method for preparing an aglycone or hydrolyzed glycoside from a glycoside by converting a glycoside into an aglycone form or hydrolyzed glycoside by using a microorganism producing ?-glycosidase, and then recovering the aglycone or hydrolyzed glycoside accumulated in the cells of the microorganism.
    Type: Application
    Filed: September 30, 2015
    Publication date: October 26, 2017
    Applicant: RNA INC.
    Inventors: Dae Kyun Chung, Hangeun Kim, Seung Su Lee, Bong Jun Jung, Hye Rim Kim, Yoon Doo Lee, Jae Yeon Park, Boram Jeon, Seong Jae Kim
  • LIPOTEICHOIC ACID-DERIVED GLYCOLIPIDS, AND COMPOSITIONS COMPRISING SAME
    Publication number: 20120190634
    Abstract: A lipoteichoic acid (LTA)-derived glycolipid, and a pharmaceutical, food or cosmetic composition and a vaccine adjuvant including the same are provided. The LTA-derived glycolipid can inhibit the production of inflammatory cytokines and thus have anti-inflammatory effects. Therefore, the pharmaceutical, food or cosmetic compositions including the LTA-derived glycolipid can be used to prevent and treat inflammatory diseases, and the LTA-derived glycolipid can be also used as the vaccine adjuvant.
    Type: Application
    Filed: August 26, 2010
    Publication date: July 26, 2012
    Applicant: RNA INC.
    Inventors: Dae Kyun Chung, Kyoung Soon Jang, Byung Gee Kim, Han Geun Kim, Na Ra Kim, Hea Young Lee, Bong Jun Jung, Tae Rahk Kim, Ji Hye Jeong